EUVIMEDEUVIMED entdecken
Crossref

Prevalence of Anemia among Patients with Solid Cancer at the Time of Diagnosis in Saudi Arabia

Haytham Dahlawi, Atheer S Almasoudi, Afaq S Joharji, Luluah Alboraie, Doaa Alamoudi, Anwar Borai

Clinical Laboratory · 2026

DOI: 10.7754/clin.lab.2025.250944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Haytham Dahlawi und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Neoplasms, Anemia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cancer represents a significant global health challenge, with elevated incidence and mortality rates, particularly in Saudi Arabia. Anemia frequently manifests as a common complication in patients diagnosed with solid tumors, often remaining undiagnosed. This study aims to evaluate the prevalence of anemia in individuals recently diagnosed with solid tumors, addressing the lack of comprehensive data on this issue. METHODS: A cross-sectional study was conducted using the records of 508 newly diagnosed cancer patients at King Abdulaziz Medical City (2014 - 2024). Eligible patients had confirmed histological diagnoses and no prior cancer treatment. Data included demographics, tumor types, and blood parameters (RBC, hemoglobin, hematocrit, MCV, MCH). Anemia was defined as hemoglobin < 11.5 g/dL in females and < 13.0 g/dL in males. RESULTS: Among the 508 patients analyzed, 47.9% were classified as anemic. Microcytic hypochromic anemia (MCHC) was the most prevalent subtype, observed in 25.2% of patients. Colorectal-related malignancies - including colon, rectal, and sigmoid cancers - showed the highest prevalence of MCHC anemia, suggesting chronic gastrointestinal blood loss and iron deficiency as major contributors. In contrast, breast, endometrial, and skin cancers exhibited predominantly non-anemic profiles. CONCLUSIONS: Anemia was prevalent in 47.9% of newly diagnosed solid tumor patients, most commonly in colorectal cancers (colon 61%, sigmoid 58%, rectal 52%), with microcytic hypochromic anemia (25.2%) as the leading type. Excluding patients with chronic illnesses and prior treatments allowed a clearer estimate of the true burden. Early screening and management are essential to reduce treatment-induced anemia and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAnemiaHumansSaudi ArabiaFemaleMalePrevalenceCross-Sectional StudiesMiddle AgedAdultAgedYoung AdultAnemia, Hypochromic

Zitieren

APA

Dahlawi, H., Almasoudi, A. S., Joharji, A. S., Alboraie, L., Alamoudi, D., & Borai, A. (2026). Prevalence of Anemia among Patients with Solid Cancer at the Time of Diagnosis in Saudi Arabia. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2025.250944

Vancouver

Dahlawi H, Almasoudi AS, Joharji AS, Alboraie L, Alamoudi D, Borai A. Prevalence of Anemia among Patients with Solid Cancer at the Time of Diagnosis in Saudi Arabia. Clinical Laboratory. 2026. doi:10.7754/clin.lab.2025.250944

BibTeX
@article{Dahlawi2026,
  author = {Dahlawi, Haytham and Almasoudi, Atheer S and Joharji, Afaq S and Alboraie, Luluah and Alamoudi, Doaa and Borai, Anwar},
  title = {Prevalence of Anemia among Patients with Solid Cancer at the Time of Diagnosis in Saudi Arabia},
  journal = {Clinical Laboratory},
  year = {2026},
  doi = {10.7754/clin.lab.2025.250944}
}
Kostenlos starten →